Entera Bio Ltd. Major Shareholders & Ownership History
| Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
|---|---|---|---|---|---|
| KNOLL CAPITAL MANAGEMENT, LLC | 11/14/2024 | 3.88 M | $7.38 M | 0.00% | 10.31% |
| SCHONFELD STRATEGIC ADVISORS LLC | 11/14/2024 | 648,600 | $1.23 M | -3.45% | 1.72% |
| PARKMAN HEALTHCARE PARTNERS LLC | 11/14/2024 | 411,076 | $781,044 | 2.38% | 1.09% |
| UBS GROUP AG | 11/14/2024 | 142,747 | $271,220 | -14.84% | 0.38% |
| RENAISSANCE TECHNOLOGIES LLC | 11/13/2024 | 61,200 | $116,280 | 6.25% | 0.16% |
| SIGNATURE ESTATE & INVESTMENT ADVISORS LLC | 11/06/2024 | 47,328 | $89,923 | 100.00% | 0.13% |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 11/14/2024 | 20,658 | $39,250 | -28.41% | 0.05% |
| CITADEL ADVISORS LLC | 11/14/2024 | 20,553 | $39,051 | 100.00% | 0.05% |
| GEODE CAPITAL MANAGEMENT, LLC | 11/12/2024 | 17,597 | $33,434 | 0.00% | 0.05% |
| ADVISOR GROUP HOLDINGS, INC. | 11/13/2024 | 16,777 | $30,198 | 0.00% | 0.04% |
| PNC FINANCIAL SERVICES GROUP, INC. | 11/08/2024 | 13,000 | $24,700 | 0.00% | 0.03% |
| CIBC WORLD MARKET INC. | 11/12/2024 | 12,500 | $24,000 | 0.00% | 0.03% |
| HIGHTOWER ADVISORS, LLC | 11/14/2024 | 11,830 | $22,000 | 0.00% | 0.03% |
| NEWEDGE ADVISORS, LLC | 11/14/2024 | 9,000 | $17,100 | 0.00% | 0.02% |
| BANK OF AMERICA CORP /DE/ | 11/14/2024 | 8,430 | $16,017 | 181.00% | 0.02% |
| CITADEL ADVISORS LLC | 11/14/2024 | 2,600 | $4,940 | 100.00% | 0.01% |
| CITADEL ADVISORS LLC | 11/14/2024 | 100 | $190 | 100.00% | 0.00% |
| GROUP ONE TRADING, L.P. | 11/14/2024 | 51 | $97 | 0.00% | 0.00% |
| JPMORGAN CHASE & CO | 12/26/2024 | 2 | $4 | 100.00% | 0.00% |
Entera Bio Ltd.institutional Ownership - FAQ's
During the previous two years, 18 institutional investors and hedge funds held shares of Entera Bio Ltd.. The most heavily invested institutionals were:
Knoll Capital Management, LLC: 3.88 M
Schonfeld Strategic Advisors LLC: 648,600
Parkman Healthcare Partners LLC: 411,076
UBS Group AG: 142,747
RENAISSANCE TECHNOLOGIES LLC: 61,200
SIGNATURE ESTATE & INVESTMENT ADVISORS LLC: 47,328
14.14% of Entera Bio Ltd. stock is owned by institutional investors.
Institutional investors have bought a total of 5.34 M shares in the last 24 months. This purchase volume represents approximately $11.52 M in transactions.